Cat.No：GM-81144AB
Product：Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
Cat.No：GM-81144AB
Product：Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
GM-81144AB-100 100μg
GM-81144AB-1mg 1mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Drug-to-Antibody Ratio (DAR) 4.0
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target SLC39A6
Clone Ladiratuzumab vedotin
Alternative Names SGN-LIV1A; Anti-LIV-1 ADC
Source / Isotype Human IgG1(KDEL), kappa
Application Positive control of Cytotoxicity Assay
Description Ladiratuzumab vedotin, also known as SGN-LIV1A and anti-LIV-1 ADC, is a humanized antibody conjugated through a proteolytically cleavable linker to MMAE to Zinc transporter LIV-1 (SLC39A6).
Formulation 20 mM Histidine, pH 6.0
Storage temp. Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.
Cat.No：GM-81144AB
Product：Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
GM-81144AB-100 100μg
GM-81144AB-1mg 1mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Drug-to-Antibody Ratio (DAR) 4.0
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target SLC39A6
Clone Ladiratuzumab vedotin
Alternative Names SGN-LIV1A; Anti-LIV-1 ADC
Source / Isotype Human IgG1(KDEL), kappa
Application Positive control of Cytotoxicity Assay
Description Ladiratuzumab vedotin, also known as SGN-LIV1A and anti-LIV-1 ADC, is a humanized antibody conjugated through a proteolytically cleavable linker to MMAE to Zinc transporter LIV-1 (SLC39A6).
Formulation 20 mM Histidine, pH 6.0
Storage temp. Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.
